CRNT is trading at $2.38 (-5.12%) as the stock extends its mid-June slide amid broader weakness in tech and higher-beta names.

  • The move aligns with general risk-off sentiment across the Nasdaq, with no clear company-specific catalysts reported.
  • The decline marks a continuation of recent downward momentum; the stock closed yesterday at $2.51 after a -4.92% drop.